PCY System | FILMARRAY Respiratory Panel
The FILMARRAY™ Respiratory Panel enables rapid and accurate automated detection of pathogens behind respiratory infections. It tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively.
Simple, comprehensive respiratory testing
The FILMARRAY Respiratory Panel tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively. It works on the FILMARRAY™ system, an FDA, CE-IVD, and TGA certified multiplex PCR system. FILMARRAY™ integrates sample preparation, amplification, detection and analysis into one simple system that requires just 2 minutes of hands-on time, with a total run time of about an hour. Rapid and accurate identification of the causative agent of upper respiratory tract infections may improve patient management by informing timely and effective antibiotic or antiviral therapy, preventing secondary spread of infection, shortening hospital stays and reducing costs of unnecessary ancillary tests.
20 targets at once
The FILMARRAY™ Respiratory Panel is incredibly comprehensive, with simultaneous testing for 20 of the most common pathogens involved in UTRI.
Panel Specifications
Sample Handling | Performance Parameters |
---|---|
Sample Type: Nasopharyngeal Swab | Hands-on time: Approx. 2 minutes |
Sample Volume: 300 μL | Run turnaround time: About an hour |
Clinical Sensitivity and Specificity of the FilmArray Respiratory Pouch
Pathogen | SENSITIVITY Prospective |
SENSITIVITY Retrospective |
SPECIFICITY Prospective |
---|---|---|---|
Adenovirus | 88.9% | 100% | 98.3% |
Bocavirus | 66.7% | 100% | 99.8% |
Coronavirus HKU1 | 95.8% | n/a | 99.8% |
Coronavirus NL63 | 95.8% | n/a | 100% |
Coronavirus 229E | 100% | n/a | 99.80% |
Coronavirus OC43 | 100% | n/a | 99.60% |
Human Metapneumovirus | 94.6% | n/a | 99.2% |
Human Rhinovirus/Enterovirus | 92.7% | 95.7% | 94.6% |
Influenza A | 90.0% | n/a | 99.8% |
Influenza A/H1 | n/a | 100% | 100% |
Influenza A/H3 | n/a | 100% | 100% |
Influenza A/H1-2009 | 88.9%* | 100% | 99.6% |
Influenza B | n/a | 100% | 100% |
Parainfluenza Virus 1 | 100%* | 97.1% | 99.9% |
Parainfluenza Virus 2 | 87.4%* | 100% | 99.8% |
Parainfluenza Virus 3 | 95.8%* | 100% | 99.8% |
Parainfluenza Virus 4 | 100%* | 100% | 99.9% |
Respiratory Syncytial Virus | 100% | n/a | 89.1% |
Bordetella pertussis | 100%* | 100% | 99.90% |
Chlamydophila pneumoniae | 100%* | n/a | 100% |
Mycoplasma pneumoniae | 100%* | 90.0% | 100% |
To contact bioMérieux Australia about PCY System | FILMARRAY Respiratory Panel use Get a quote.
The FILMARRAY™ Respiratory Panel enables rapid and accurate automated detection of pathogens behind respiratory infections. It tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively.
Simple, comprehensive respiratory testing
The FILMARRAY Respiratory Panel tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively. It works on the FILMARRAY™ system, an FDA, CE-IVD, and TGA certified multiplex PCR system. FILMARRAY™ integrates sample preparation, amplification, detection and analysis into one simple system that requires just 2 minutes of hands-on time, with a total run time of about an hour. Rapid and accurate identification of the causative agent of upper respiratory tract infections may improve patient management by informing timely and effective antibiotic or antiviral therapy, preventing secondary spread of infection, shortening hospital stays and reducing costs of unnecessary ancillary tests.
20 targets at once
The FILMARRAY™ Respiratory Panel is incredibly comprehensive, with simultaneous testing for 20 of the most common pathogens involved in UTRI.
Panel Specifications
Sample Handling | Performance Parameters |
---|---|
Sample Type: Nasopharyngeal Swab | Hands-on time: Approx. 2 minutes |
Sample Volume: 300 μL | Run turnaround time: About an hour |
Clinical Sensitivity and Specificity of the FilmArray Respiratory Pouch
Pathogen | SENSITIVITY Prospective |
SENSITIVITY Retrospective |
SPECIFICITY Prospective |
---|---|---|---|
Adenovirus | 88.9% | 100% | 98.3% |
Bocavirus | 66.7% | 100% | 99.8% |
Coronavirus HKU1 | 95.8% | n/a | 99.8% |
Coronavirus NL63 | 95.8% | n/a | 100% |
Coronavirus 229E | 100% | n/a | 99.80% |
Coronavirus OC43 | 100% | n/a | 99.60% |
Human Metapneumovirus | 94.6% | n/a | 99.2% |
Human Rhinovirus/Enterovirus | 92.7% | 95.7% | 94.6% |
Influenza A | 90.0% | n/a | 99.8% |
Influenza A/H1 | n/a | 100% | 100% |
Influenza A/H3 | n/a | 100% | 100% |
Influenza A/H1-2009 | 88.9%* | 100% | 99.6% |
Influenza B | n/a | 100% | 100% |
Parainfluenza Virus 1 | 100%* | 97.1% | 99.9% |
Parainfluenza Virus 2 | 87.4%* | 100% | 99.8% |
Parainfluenza Virus 3 | 95.8%* | 100% | 99.8% |
Parainfluenza Virus 4 | 100%* | 100% | 99.9% |
Respiratory Syncytial Virus | 100% | n/a | 89.1% |
Bordetella pertussis | 100%* | 100% | 99.90% |
Chlamydophila pneumoniae | 100%* | n/a | 100% |
Mycoplasma pneumoniae | 100%* | 90.0% | 100% |
To contact bioMérieux Australia about PCY System | FILMARRAY Respiratory Panel use Get a quote.
Thanks for your help!
Sorry! Unable to submit your request at this time. Please try again later.
Report this product